Loading...
Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Tumour necrosis factor (TNF)-α is a key mediator of inflammation in rheumatoid arthritis, and its discovery led to the development of highly successful anti-TNF therapy. Subsequently, other biologic drugs targeting immune pathways, namely interleukin-6 blockade, B cell depletion, and T cell co-stimu...
Na minha lista:
| Udgivet i: | J Pers Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963853/ https://ncbi.nlm.nih.gov/pubmed/31581724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm9040046 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|